Navigation Links
Aspirin Found To Reduce The Risk Of Colon Cancer

New research shows consuming higher doses of aspirin may reduce the risk of colon polyps, which can develop // into cancer.

Researchers studied about 27,000 women between 34 and 77 years old. The participants underwent endoscopic colon exams between 1980 and 1998. During the 18 years, nearly 1,400 of the women were diagnosed with adenoma, a type of polyp known to be precancerous.

Results show participants who reported taking aspirin regularly were 25-percent less likely to have adenoma than those who did not take aspirin. Women who had the lowest risk of developing polyps reported taking more than two aspirins per day. Researchers say current guidelines suggest low doses (one small tablet) of aspirin are as effective as higher doses for heart disease prevention. High doses of aspirin are associated with a greater risk of side effects such as internal bleeding.

Despite the encouraging results, researchers say more studies are needed to confirm their findings and determine the safest dose. Researchers say until their findings are confirmed, people should follow the current guidelines for aspirin consumption.
'"/>




Page: 1

Related medicine news :

1. What happens when Asthmatics consume Aspirin?
2. Aspirin reduces deaths
3. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
4. Aspirin - a drug after one’s own hear
5. Aspirin deflated
6. Aspirin surpasses Modern Anti-clotting Drugs
7. Night Time Aspirin Regimen Found to Reduce Blood Pressure
8. Aspirin Lowers Leukemia Risk
9. Aspirin usage linked with pancreatic cancer
10. Aspirin Induced Asthma , A Little-Known Inducer
11. Aspirin Found To Be Effective In Reducing Breast Cancer Rates

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Aspirin Found Reduce The Risk Colon Cancer

(Date:11/27/2009)..., , DALLAS, Nov. 27 /PRNewswire-USNewswire...edical procedure only 25 years ago, solid organ tr...ation thanks to the extraordinary men and women wh...n Nov. 11. Leaders came together from medical cent...sary of Baylor Regional Transplant Institute (BRTI...
(Date:11/27/2009)... XenaCare Holdings has an...he Arthritis Foundation, one of the largest nonpro...and public health education. , ...- XenaCare Holdings, Inc. (OTCBB: XCHO), a company...tion of consumer healthcare products, has announce...
(Date:11/27/2009)... Multi-purpose bilingual ... Designed for use by the business community to edu...ety of subjects from Safety issues to Dinosuars to... Saint Louis, MO (PRWEB) November 27, 2... electronics or toys to keep them busy any hour of...
(Date:11/26/2009)... In the next 25 years, the number of Americans li...from 23.7 million in 2009 to 44.1 million in 2034....lmost triple, rising from $113 billion to $336 bil...besity, researchers based at the University of Chi...e . , The number of those with diabetes covered ...
(Date:11/26/2009)... Dr. David Kim of the Liv...oss surgery in Dallas , is one of a growing number...r social networking sites to connect with individu...atment to fight morbid obesity. Dr. Kim is utilizi...nformation about his practice with the community. ...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3
... that zolpidem, temporarily improved brain functio... patient was able to communicate// , walk, and eat... bout of insomnia. Zolpidem is a drug norma...he March 2007 issue of Annals of Neurology (http:/...
...abourers of a Bihar village affected by Kala Azar,...rnment's plan// to check the spread of the deadly ...k and mortar is all set to become a reality for th...hey will be provided houses by the central governm...
...ers and seamstresses, cheer up. That stinging pain...rience in your wrists//, may not be a result of ca...TS, more often than not, leads one straight to the... CTS happens when a nerve passing through your ...
...n Infant Death Syndrome (SIDS), the third leading ...use of a pacifier//. According to an article in Nu...ctitioners should counsel new parents on the poten...orce on SIDS, suggesting that pacifier use be enco...
...,' or baseline condition when the brain is idling,...zophrenia and this aberrant activity// may be caus...Yale School of Medicine researcher reports. ...lly abnormal in patients with schizophrenia, also ...
...d to be passed in South Carolina, which will enabl...onate their kidneys//. If this bill is passed, the... jail by as many as 180 days. Democratic Senat...n donors. According to ABC report there are around...
Other Medicine News:Health News:Zolpidem Might Assist Patients With Akinetic Mutism 2Health News:Harbinger of Hope for Kala Azar Victims of Bihar 2Health News:Computer Programmers, need not fear Carpal Tunnel Syndrome 2Health News:Brain’s "Default Mode" Awry in Schizophreni 2
(Date:11/25/2009)..., N.J., Nov. 25 Pharmass...ceutical company committed to discovering, develop... infections, reported financial results for the fi...0, 2009 Pharmasset held $58.4 million in cash, cas...Pipeline Update and 2009 Highlights ,, RG7128...
(Date:11/25/2009)..., N.J., Nov. 25 The FDA granted tr...) tablets, a non-nucleoside reverse transcriptase ...cifically indicated for use in treatment-experienc...ith HIV-1 strains resistant to an NNRTI and other ...oval is based on 48-week data from two Phase 3 stu...
(Date:11/25/2009)...IDGE, N.J., Nov. 25 Regado Bioscie...ment of antithrombotic aptamers with active contro... President, will be presenting at the Piper Jaffra...rk Palace Hotel in New York City. Dr. Mazzo,s pre..., December 1 and will include an overview of the C...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Nepali Home Minister Commends Narconon International for Saving Lives 56495 1Nepali Home Minister Commends Narconon International for Saving Lives 56495 2Helix BioPharma Closes Private Placement 13918 1Helix BioPharma Closes Private Placement 13918 2Helix BioPharma Closes Private Placement 13918 3JDRF funded studies show regular CGM use increases diabetes control for all age groups 9833 1JDRF funded studies show regular CGM use increases diabetes control for all age groups 9833 2JDRF funded studies show regular CGM use increases diabetes control for all age groups 9833 3JDRF funded studies show regular CGM use increases diabetes control for all age groups 9833 4JDRF funded studies show regular CGM use increases diabetes control for all age groups 9833 5
...product in,AM-Pharma,s pipeline , BUNNIK, The Neth...armaceutical company developing novel therapeutics...day announced positive,results in patients with Ac...bgroup of a Phase IIa trial with Alkaline Phosphat..., a marker for renal function,improved by 45% (me...
...Institut (SSI) and Intercell, report promising d...tuberculosis (TB) subunit vaccine , , » ... Intercell’s,adjuvant IC31™ , , &raq...e European Union aims to,either , replace t...almette vaccine” or,to , boost its ac...
Other Medicine Technology:AM-Pharma Announces Positive Results of a Phase IIa Clinical Trial,with Alkaline Phosphatase in Acute Renal Failure 2AM-Pharma Announces Positive Results of a Phase IIa Clinical Trial,with Alkaline Phosphatase in Acute Renal Failure 3Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 2Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 3Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 4
...ucts for autoimmune testing feature single-well AN...c reflex tests including dsDNA, and 6 individual E...and Jo-1. In addition, our autoimmune ELISA family... (IgA, IgG, IgM), Thyroglobulin, Thyroid Microsoma...
Suture Ring
Digital ClearField Lens
Crypto-LA® Cryptococcal Antigen Test
Medicine Products: